Funding push to pharma R&D critical for unleashing next phase of growth
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
Taluka level transplant centre will add convenience to patients from rural areas
The transplant procedure was completed in under two hours
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
India reports 18 lakh stroke cases a year with 25 per cent patients below the age of 50
The platform will be a curated marketplace for sustainable-driven products by small-medium entrepreneurs and will encourage an autonomous marketplace
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The cloud-based platform enables long-term brain monitoring towards personalized treatment
Subscribe To Our Newsletter & Stay Updated